Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Historique des dividendes AVDL
Analyse des dividendes AVDL
Max Ratio
–Croissance des dividendes sur 5 ans
–Croissance continue
–Ratio de distribution Moyenne sur 5 ans
–Avadel Pharmaceuticals PLC
AVDLAvadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is the LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of cataplexy or excessive daytime sleepiness in patients seven years of age and older with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin 2, Ireland. Address: 10 Earlsfort Terrace, Dublin, Ireland, D02 T380
Analytics
Objectif de Cours de WallStreet
16.57 USDRatio C/B
–Rendement du dividende
–financières AVDL
Résultats | 2019 | Dynamique |